Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A comprehensive review study
Spencer JP, Thomas S, Trondsen Pawlowski RH
The National Institute on Drug Abuse is sponsoring a clinical trial this year evaluating tirzepatide, the active ingredient in Eli Lillys weight-loss drugs, as a potential treatment for cannabis use disorder
Discussion We previously demonstrated that elevating Rab7-GTP levels upon Rab7-GAP TBC1D15 gene depletion enabled activation of cholesterol export routes from LE/Lys, reducing cholesterol accumulation in NPC1 mutant cells [12]
US$ 26.10
US$ 25.83
US$ 29.75
US$ 22.42
US$ 25.09
